MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2016 International Congress

    Effects of dual task on upper extremity function and postural control in patients with Parkinson’s disease

    S.M.A.A. Pompeu, B.R.B. Moraes, J.E. Pompeu (São Paulo, Brazil)

    Objective: To verify the performance and pattern of prioritization of patients with Parkinson's disease in motor and cognitive dual tasks with different demands. Background: Patients…
  • 2016 International Congress

    Cognitive functioning in Parkinson’s disease and Parkinson plus syndrome

    S. Mina, V.K. Verma, K.S. Anand (New Delhi, India)

    Objective: Our study aimed to investigate and compare the cognitive functioning in PD and PPS. Background: Parkinson[s] disease (PD) is now known to be associated…
  • 2016 International Congress

    Cognitive decline in Parkinson’s disease: Impact on quality of life of caregivers

    R.A. Lawson, A.J. Yarnall, G.W. Duncan, F. Johnston, T.K. Khoo, D. Collerton, J.P. Taylor, D.J. Burn (Newcastle upon Tyne, United Kingdom)

    Objective: This study aimed to investigate the impact of cognitive impairment in Parkinson's disease (PD) on the quality of life (QoL) of carers. Background: The…
  • 2016 International Congress

    Association of Parkinson’s disease severity and cortical and subcortical cognitive markers

    H. Duran-Meza, A.D. Santana-Vargas, J.D. Ramirez-Diossa, G.H. Terrazas Gonzalez, G. Millan-Rosas, U. Jimenez-Correa, M. Lopez-Ruiz (Mexico City, Mexico)

    Objective: To assess cortical and subcortical dysfunction in several stages of Parkinson's disease (PD) using the Parkinson's disease-cognitive rating scale (PD-CRS). Background: Cognitive impairment in…
  • 2016 International Congress

    Neuropsychological subgroups in non-demented Parkinson’s disease: A latent class analysis

    L. Brennan, K. Devlin, S.X. Xie, D. Mechanic-Hamilton, B. Tran, H. Hurtig, A. Chen-Plotkin, L. Chahine, J.F. Morley, J.E. Duda, D.R. Roalf, N. Dahodwala, J. Rick, J.Q. Trojanowski, P.J. Moberg, D. Weintraub (Philadelphia, PA, USA)

    Objective: Identify discrete cognitive phenotypes in a cohort of 199 non-demented Parkinson's disease (PD) patients. Background: Methods to detect early cognitive decline and account for…
  • 2016 International Congress

    Optogenetic silencing of locus coeruleus activity in mice impairs cognitive flexibility in an attentional set-shifting task

    K. Janitzky, M. Lippert, A. Engelhorn, J. Tegtmeier, J. Goldschmidt, H.J. Heinze, F.W. Ohl (Magdeburg, Germany)

    Objective: In this study we used unilateral optogenetic silencing of the LC in an attentional set-shifting task (ASST) to evaluate the influence of the LC…
  • 2016 International Congress

    Synaptic biomarkers for cognitive decline in Lewy body dementias and Alzheimer’s disease. A mass spectrometry approach

    E. Bereczki, R.M.M. Branca, P.T. Francis, J.H. Baek, J. Lehtio, D. Aarsland (Huddinge, Sweden)

    Objective: The aim of our study is to understand the role of synaptic dysfunction in cognitive decline by comparing the whole proteome of Parkinson's disease…
  • 2016 International Congress

    Circulatory levels of BDNF correlate with cognitive deficits in people with Parkinson’s disease

    H. Khalil, M.A. Alomari, O.F. Khabour, A. Al-Hieshan, J.A. Bajwa (Irbid, Jordan)

    Objective: The aim of this study was to examine the relationship of serum BDNF levels with cognitive function. Background: Brain-derived neurotrophic factor (BDNF) is essential…
  • 2016 International Congress

    A technological solution for monitoring Parkinson’s disease: A patient-based perspective on necessity, usability and acceptability

    S. Couth, E. Poliakoff, J. Vega, C. Jay, S. Harper, R. Almutiry, T.F. Cootes, A.M. Ramsay, S.A. Kotz (Manchester, United Kingdom)

    Objective: The objectives of this study were twofold. First, to determine the feasibility of monitoring changes in how people with Parkinson's feel, think, and behave…
  • 2016 International Congress

    Mild cognitive impairment is linked with white matter degeneration in the cortico-subcortical tracts in patients with Parkinson’s disease

    A. Hanganu, J.C. Houde, V.S. Fonov, C. Degroot, B. Mejia-Constain, A.L. Lafontaine, V. Soland, S. Chouinard, L.D. Collins, M. Descoteaux, O. Monchi (Calgary, Canada)

    Objective: Evaluate the correlation between brain tractography changes in patients with Parkinson's disease (PD) with and without mild cognitive impairment (MCI). Background: Up to 40%…
  • « Previous Page
  • 1
  • …
  • 120
  • 121
  • 122
  • 123
  • 124
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley